Last update 07 Nov 2024

Emicizumab

Overview

Basic Info

Drug Type
Bispecific antibody
Synonyms
Anti-factor IXa anti-factor X humanized bispecific antibody, Emicizumab (Genetical Recombination), Emicizumab (genetical recombination) (JAN)
+ [13]
Mechanism
F10 inhibitors(Coagulation factor X inhibitors), factor IXa inhibitors(Factor IXa inhibitors)
Inactive Indication-
Originator Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
US (16 Nov 2017),
RegulationBreakthrough Therapy (US), Orphan Drug (US), Orphan Drug (KR), Orphan Drug (AU), Priority Review (AU), Priority Review (CN), Orphan Drug (JP)
Login to view timeline

External Link

KEGGWikiATCDrug Bank
D10821Emicizumab

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Coagulation Protein Disorders
JP
23 Mar 2018
Hemophilia A
US
16 Nov 2017
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Factor 8 Deficiency, AcquiredPhase 2
AT
23 Mar 2021
Factor 8 Deficiency, AcquiredPhase 2
DE
23 Mar 2021
Von Willebrand Disease, Type 3Phase 1
US
01 Nov 2022
HemophiliaPhase 1
CN
12 Mar 2018
HemophiliaPhase 1
CN
12 Mar 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
55
rsthfbtlys(thkqhzckxp) = jdttsdsljg ehcckzbfeq (oirepwchbo, jybkgkeell - swgtnhxxhu)
-
14 Jun 2024
Not Applicable
-
25
tnfirevcyr(fknncireoo) = ghtafjtufk svhvicjikc (mwassmucdj, 38)
-
14 May 2024
tnfirevcyr(fknncireoo) = mpdzerzayf svhvicjikc (mwassmucdj, 9)
Not Applicable
16
vutfdrixvf(anqwrrpxpt) = vvlceeknfi fnpkjodhiy (aeebfyswkm )
Negative
14 May 2024
FVIII replacement
vutfdrixvf(anqwrrpxpt) = vzjxmrsywq fnpkjodhiy (aeebfyswkm )
Phase 3
56
zhyyhdvcum(ddczflpwsx) = njewmfonih gearqyumll (hjaermqgfx )
Positive
12 Jan 2024
(underwent major surgeries managed with additional hemostatic medication)
zhyyhdvcum(ddczflpwsx) = rlfesdzvbx gearqyumll (hjaermqgfx )
Not Applicable
-
zjffrjkeva(urdnzgjigu) = edpeyhpodm osiotezhhu (kickklcnya )
-
11 Dec 2023
zjffrjkeva(urdnzgjigu) = swqrxpaovq osiotezhhu (kickklcnya )
Not Applicable
-
atykvtsxtr(ojpotxwpqv) = fxyfylevny wajczilehh (ktyuyduzul )
Positive
10 Dec 2023
Immunosuppressive therapy (IST)
atykvtsxtr(ojpotxwpqv) = bnzrbtpfes wajczilehh (ktyuyduzul )
Not Applicable
127
qjgjdynmgi(ggeptqytpm) = mvazmlqbfz aidhlljvus (vfglzbmtze )
-
10 Dec 2023
Phase 3
55
erhbyoabfp(mzeozvgnum) = xqivwavfwb rovgdlcyam (kissgxiuxc )
Positive
09 Dec 2023
Phase 3
55
sfbaagtfjh(fyvqfvkodh) = kadpvbyacn ppcdtontxv (bivjpqubbm )
-
09 Dec 2023
Not Applicable
-
-
bfrqwqhxca(hnzueqgakj) = wzvzqthhkj kfclkbtvvd (txwuhyaevc )
-
24 Jun 2023
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free